IκB激酶酸化细胞质TDP-43并促进其蛋白质体降解
Yohei Iguchi1, Yuhei Takahashi1, Jiayi Li1
1Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
The Journal of cell biology
|January 10, 2024
概括
IκB激酶 (IKK) 复合体降解细胞质TDP-43,这是一种涉及ALS和FTLD的蛋白质. 向IKK和TDP-43酸化可能为这些神经退行性疾病提供新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 细胞质聚合TDP-43是神经退行性疾病的标志,如肌缩侧面硬化症 (ALS) 和前叶退化症 (FTLD).
- 了解控制TDP-43水平和聚合的监管机制对于开发有效的治疗方法至关重要.
研究的目的:
- 研究IκB激酶 (IKK) 综合体在细胞质TDP-43.3降解中的作用.
- 确定 IKK 监管的 TDP-43 上的特定酸化位点及其功能意义.
- 评估针对ALS和FTLD模型中的IKK-TDP-43途径的治疗潜力.
主要方法:
- 细胞测试用于研究由IKK复合体介导的TDP-43降解.
- 质谱测量以确定IKKβ诱导的TDP-43酸化位点.
- 在疾病模型中分析TDP-43酸化模式.
- 使用小鼠模型进行体内研究,以评估IKKβ对TDP-43聚合的影响.
主要成果:
- 该IKK复合体,特别是IKKβ,促进细胞质TDP-43的蛋白质体降解.
- 在这种降解过程中,IKKα和NEMO分别起到辅助因素和支架的作用.
- 通过IKKβ对TDP-43在Thr8和Ser92的酸化对其减少至关重要.
- IKKβ减少了与疾病相关的TDP-43突变的表达和毒性,并减轻了小鼠海马中的TDP-43聚合.
结论:
- 该IKK复合体在通过蛋白质体降解来调节TDP-43水平方面发挥着重要作用.
- IKK对TDP-43的N端酸化对其营业额很重要.
- 向IKK复合物和TDP-43的N端酸化是对ALS和FTLD的一个有希望的治疗途径.
相关概念视频
The Unfolded Protein Response
4.6K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.6K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Regulated Protein Degradation
7.3K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.3K
The Proteasome
845
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
845
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


